Scientists appraise current literature, opportunities, and challenges associated with liquid biopsy and pharmacogenomic testing as precision therapy tools in the management of epidermal growth factor receptor (EGFR) mutant and resistant lung cancers.
[Molecular Cancer]
6445212
AAAAAAAA
items
1
apa
0
default
asc
1
172442
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
